Menopause Medications List 2026: Hormonal, Non-Hormonal & Compounded Options
By The HRT Index Editorial Team · · Educational only — not medical advice · Affiliate disclosure · Privacy policy
Here’s the short version.
The menopause medications list for 2026 breaks into a handful of groups: systemic hormone therapy (estrogen, sometimes with progesterone, that works through your whole body), local vaginal estrogen (that works mostly where you put it), non-hormonal prescription drugs for hot flashes — including the two newest, Veozah and Lynkuet — plus medicines for vaginal and sexual symptoms and, new for late 2025, an FDA-approved pill for low sexual desire in postmenopausal women (Addyi).
Which one is right for you depends on three things: your main symptom, whether you still have a uterus, and whether you can — or want to — take hormones. And here’s the part most “2026” articles completely miss: in February 2026, the FDA started removing specific boxed-warning language from some menopausal hormone therapy labels — and we’ll show you exactly which products have changed and which haven’t.
Every medication and date on this page was checked against FDA and DailyMed sources.
Is this the right page for you?
| This page is for you if… | You may want a different page if… |
|---|---|
| You want the full, current picture of what’s available before a doctor’s visit. | You already know your exact medication and just need the cheapest pharmacy price. |
| You’re weighing hormones vs. non-hormonal options. | You have unexplained bleeding, chest pain, or stroke-like symptoms — that’s an in-person visit, today. |
| Someone mentioned a drug (Veozah? “bioidentical”? patches?) and you want to place it. | You need a diagnosis or personal medical advice — that’s a clinician’s job, not an article’s. |
| You’re confused by estrogen, progesterone, and everything in between. | You have a complex cancer, clotting, liver, or heart history that needs a specialist first. |
The one thing an article can’t do — and what to do instead
No list can tell you which of these medications is right for you.Not this one, not any of them. Anyone who names a single “best menopause medication” for everyone is selling something. The right choice runs through your symptoms, your body, and your history. The HRT Index’s Find My HRT Path tool matches your situation to the right provider — including flagging when online care isn’t the right starting point.
Not sure which of these medications fits your symptoms and history?
Get your personalized action plan with Find My HRT Path. It’s free, takes about 90 seconds, and points you toward the right kind of care before you spend a dollar on a consult.
Find My HRT Path →Find My HRT Path asks health-related questions — see our privacy policy before you start.
Menopause medications list 2026: every category at a glance
Menopause medications in 2026 fall into a few practical groups: systemic hormone therapy, local vaginal estrogen, FDA-approved non-hormonal drugs for hot flashes, medicines for vaginal and sexual symptoms, an FDA-approved option for low desire, plus off-label and compounded options.FDA-approved products have been tested and reviewed to a set standard. Compounded hormones have not — they’re a separate lane, and we keep them separate all the way through.
Read the table by symptom first. Find your main problem, and the rest of the page zooms in from there.
| Group | Common examples | Hormone? | FDA status | Best for | How it’s taken |
|---|---|---|---|---|---|
| Systemic estrogen | Estradiol; conjugated estrogens (Premarin) | Yes | FDA-approved | Hot flashes, night sweats; some bone-loss prevention | Pill, patch, gel, spray |
| Estrogen + progestogen | Bijuva, Prempro, Activella, CombiPatch, Angeliq, Climara Pro | Yes | FDA-approved | Same as above, for women with a uterus | Pill or patch |
| Estrogen + bazedoxifene | Duavee | Yes | FDA-approved | Hot flashes + bone protection, no progestogen needed | Pill |
| Local vaginal estrogen | Estrace cream, Premarin cream, Vagifem, Yuvafem, Imvexxy, Estring | Yes (low, local) | FDA-approved | Vaginal dryness, painful sex | Cream, tablet, insert, ring |
| Non-hormonal for hot flashes | Brisdelle / generic paroxetine 7.5 mg; Veozah (fezolinetant); Lynkuet (elinzanetant) | No | FDA-approved | Hot flashes when you can’t or won’t take estrogen | Pill |
| Vaginal/sexual symptoms (non-estrogen) | Osphena (ospemifene); Intrarosa (prasterone) | Not estrogen | FDA-approved | Painful sex (both); Osphena also treats vaginal dryness | Pill or vaginal insert |
| Low desire / HSDD | Addyi (flibanserin); Vyleesi (bremelanotide) | No | FDA-approved | Diagnosed low sexual desire — Addyi now covers women under 65 incl. postmenopausal (Dec 2025); Vyleesi is premenopausal only | Pill or injection |
| Off-label for hot flashes | Venlafaxine, gabapentin, clonidine, oxybutynin | No | Used off-label | Hot flashes/sleep in select cases | Pill/capsule |
| Compounded hormones | Custom creams, capsules, pellets | Varies | Not FDA-approved | Marketed broadly; verify carefully | Cream, capsule, pellet, troche |
The first seven groups are FDA-approved. Off-label means an approved drug used for a purpose the FDA hasn’t specifically signed off on, and compounded means custom-mixed and not FDA-approved at all. We’ll cover both below.
Hot flashes and night sweats hit up to 75% of women during menopause, and about 1 in 5 still get them into their 60s and 70s. If this feels like it’s going on longer than anyone warned you — you’re not imagining it.
Which of these are FDA-approved?
Seven of the groups above are FDA-approved, meaning they’ve been tested and reviewed for how well they work and how safe they are. For hot flashes: systemic estrogen, estrogen-plus-progestogen combinations, estrogen-plus-bazedoxifene (Duavee), and the non-hormonal pills Brisdelle, Veozah, and Lynkuet. For vaginal and sexual symptoms: low-dose vaginal estrogen, Osphena, and Intrarosa. For diagnosed low desire: Addyi and Vyleesi.
Two groups are not FDA-approved in the same way. Off-label medicines (like venlafaxine or gabapentin) are approved drugs a clinician may prescribe for hot flashes even though the FDA approved them for something else. Compounded hormones aren’t FDA-approved at all. Knowing which lane a medication is in is one of the most useful things you can walk into an appointment already understanding.
See the full 2026 FDA-approved HRT medication list for the complete product-by-product breakdown.
What changed in 2026: FDA removed specific boxed-warning language from six hormone products
On February 12, 2026, the FDA approved new labels for the first six menopausal hormone therapy products — removing the “boxed warning” language about cardiovascular disease, breast cancer, and probable dementia. The FDA said the older warning didn’t match the current science for most women who start hormones near menopause. It did not remove every warning, and more products are being reviewed. It does not make hormone therapy risk-free.
A “boxed warning” (sometimes called a black-box warning) is the strongest warning the FDA puts on a drug label. For years, hormone therapy carried one, and by the FDA’s own numbers, a lot of women stayed away because of it: in 2020, of roughly 41 million U.S. women aged 45–64, only about 2 million were on hormone therapy. After a full review of the research, the FDA began removing that specific warning language from six products.
The 2026 FDA label-change tracker
| Product | What it is | Label updated by FDA? | Date |
|---|---|---|---|
| Prometrium | Progesterone | ✓ Yes | Feb 12, 2026 |
| Divigel | Estradiol gel | ✓ Yes | Feb 12, 2026 |
| Cenestin | Synthetic conjugated estrogens (A) | ✓ Yes | Feb 12, 2026 |
| Enjuvia | Synthetic conjugated estrogens (B) | ✓ Yes | Feb 12, 2026 |
| Estring | Estradiol vaginal ring | ✓ Yes | Feb 12, 2026 |
| Bijuva | Estradiol + progesterone | ✓ Yes | Feb 12, 2026 |
| Premarin, Estrace, Climara, Vivelle-Dot, Prempro, Vagifem, Imvexxy, and others | All categories | Not yet listed by the FDA | Not yet (as of July 8, 2026) |
Only these six products appear as updated on the FDA’s own list. More may be added as the FDA reviews the rest of the 29 submissions. We re-check this list monthly — last confirmed July 2026.
Three things nobody tells you in the headline
- “Warning removed” does not mean “risk-free.” The FDA pointed to studies showing women who start hormone therapy within 10 years of menopause (usually before age 60) can see lower overall death rates and fewer fractures. The FDA also kept the boxed warning about uterine cancer for estrogen-only products in women who still have a uterus.
- This change does not touch Veozah.Veozah is a non-hormonal drug and has its own separate warning about rare liver injury. The 2026 hormone-label update doesn’t change that.
- This change does not make compounded hormones “approved.”Compounded products were never FDA-approved, and this update doesn’t change that either.
Which menopause medication matches your symptom?
The best medication group depends on what’s actually bothering you. Hot flashes and night sweats usually point to whole-body options. Vaginal dryness and painful sex usually point to local or vaginal-specific treatment. Low desire, sleep, and bone health each need their own conversation.
| Your main symptom | Options usually discussed | Whole-body or local? | The question to ask next |
|---|---|---|---|
| Hot flashes / night sweats | Systemic estrogen (plus progestogen if you have a uterus); Brisdelle; Veozah; Lynkuet; some off-label pills | Whole-body | “Am I a hormone candidate, or should I go non-hormonal?” |
| Vaginal dryness | Low-dose vaginal estrogen; Intrarosa; Osphena; moisturizers/lubricants | Mostly local | “Are my symptoms only vaginal, or do I have hot flashes too?” |
| Painful sex | Vaginal estrogen; Intrarosa; Osphena; lubricants; pelvic floor help | Local | “Is this dryness, or pain that needs a real exam?” |
| Sleep disruption | Treat the night sweats if that’s the cause; some non-hormonal options; sleep check | Depends | “Is this night sweats, insomnia, sleep apnea, or anxiety?” |
| Low libido | Treat pain/dryness first; HSDD evaluation; Addyi for women under 65; testosterone is off-label | Depends | “Is this desire, pain, a medication side effect, or something else?” |
| Bone protection | Systemic estrogen for some women; Duavee; bone-specific drugs | Whole-body | “Is my goal symptom relief, bone protection, or both?” |
Found your symptom but not sure which option fits your history?
Match your situation with Find My HRT Path. About 90 seconds, no cost, and it flags when you should see someone in person first.
Find My HRT Path →Hormone therapy options: estrogen, progesterone, and combinations
Hormone therapy replaces some of the estrogen your body stops making at menopause. The main FDA-approved types are estrogen alone, estrogen plus a progestogen, estrogen plus bazedoxifene, and low-dose vaginal estrogen. Your route (pill, patch, gel, spray, or vaginal) and whether you have a uterus shape the choice.
Two quick definitions, then we’ll keep it simple:
- Systemic means it travels through your whole body — good for hot flashes and night sweats.
- Local means it mostly works where you put it — good for vaginal symptoms, with very little reaching the rest of your body.
Estrogen-only therapy(like estradiol patches, pills, gels, and sprays, or conjugated estrogens such as Premarin) is the core treatment for hot flashes and night sweats. Patches, gels, and sprays go through the skin, which skips the “first pass” through your liver that a swallowed pill goes through — one reason many clinicians like them for women with certain risk factors.
Estrogen plus a progestogen is for women who still have a uterus. Estrogen alone can thicken the uterine lining over time and raise the risk of uterine cancer, so a progestogen (like micronized progesterone — brand name Prometrium — or a synthetic progestin) is added to protect it. You can get these as two separate medicines or as one combination product, like Bijuva(the first FDA-approved combination that uses “bioidentical” estradiol and progesterone), Prempro, Activella, Angeliq, CombiPatch, or Climara Pro.
Estrogen plus bazedoxifene (Duavee) is a lesser-known option: bazedoxifene protects the uterine lininginstead of a progestogen, and it also helps prevent bone loss. Worth knowing it exists.
Low-dose vaginal estrogen (Estrace cream, Premarin cream, Vagifem, Yuvafem, Imvexxy, Estring) targets vaginal dryness and painful sex with very little estrogen reaching the rest of the body. This is not the same as whole-body HRT. See our vaginal estrogen guide for the full picture.
“Bioidentical” — what that word really means
“Bioidentical” just means the hormone has the same molecular structure as the one your body makes. That’s it. It does notmean safer, more natural, or better. And here’s the key point people get wrong: plenty of FDA-approved products are already bioidentical— estradiol, micronized progesterone, and combinations like Bijuva. You do not have to go to a compounding pharmacy to get “bioidentical” hormones. FDA-approved, tested, and consistent — those matter a lot more than a marketing word.
Full explainer: FDA-approved vs. compounded HRT — the difference that matters most.
Non-hormonal medications for menopause, including the newest ones
If you can’t or don’t want to take hormones, the FDA-approved non-hormonal options for hot flashes are Brisdelle, Veozah, and Lynkuet.Doctors also prescribe some antidepressants, gabapentin, or clonidine off-label. For vaginal symptoms without estrogen, Osphena and Intrarosa are FDA-approved. Non-hormonal doesn’t automatically mean “safer for everyone” — it means the medicine doesn’t use estrogen to work.
The FDA-approved non-hormonal pills for hot flashes
| Medication | Generic name | How it works | What to know |
|---|---|---|---|
| Brisdelle (also generic paroxetine 7.5 mg) | Paroxetine 7.5 mg | A low-dose form of an antidepressant, at a dose made just for hot flashes | The only FDA-approved SSRI for hot flashes. Carries the standard antidepressant warning about suicidal thoughts in young people, and can reduce the effect of the breast cancer drug tamoxifen. |
| Veozah | Fezolinetant | Blocks a brain signal (the NK3 receptor) that triggers hot flashes | Approved May 2023. Carries a boxed warning for rare but serious liver injury. Requires liver blood tests before starting, then monthly for the first 3 months, and again at months 6 and 9. Not for women with cirrhosis, severe kidney problems, or those taking certain interacting medicines. |
| Lynkuet | Elinzanetant | Blocks two brain signals (NK1 and NK3); the newest non-hormonal option | FDA-approved October 24, 2025. Needs liver blood tests before starting and again at about 3 months. Not for use in pregnancy, and used with caution if you have a seizure history. |
Veozah and Lynkuet are the real news.They don’t use hormones at all. They calm the part of the brain that controls body temperature, which is where hot flashes actually start. In Veozah’s two main 12-week studies, women started with about 10 to 12 moderate-to-severe hot flashes a day; by week 12, Veozah cut that by roughly 6 to 7 a day. For many women who can’t take estrogen — including breast cancer survivors — that’s a real door opening.
The honest catch
“Non-hormonal” is not a magic word that means “risk-free.”Brisdelle isn’t right if you’re on tamoxifen. Veozah needs regular liver blood tests and isn’t for everyone. These are good options — but they still need a real conversation, not a blind order. The upside: because you know the tradeoffs, you can pick the one that actually fits.
Off-label options (used, but not FDA-approved for menopause)
Some medicines weren’t designed for menopause but are prescribed for hot flashes when they fit: certain antidepressants (like venlafaxine or escitalopram), gabapentin (a nerve/seizure medicine), clonidine (a blood pressure medicine), and oxybutynin(usually a bladder medicine). “Off-label” means a clinician is prescribing an approved drug for a use the FDA hasn’t specifically signed off on — which is common and legal, but you deserve to know that’s what’s happening. The Menopause Society’s non-hormone guidance supports several of these.
What about over-the-counter?
There is no over-the-counter, whole-body menopause medication. Systemic hormones and the prescription non-hormonal drugs all need a prescription. What you can buy without one are vaginal moisturizers and lubricants, which genuinely help with dryness. As for herbal and plant supplements, ACOG notes that very few have been well studied for safety or efficacy, so treat big promises with a raised eyebrow.
For providers that specialize in non-hormonal options, see our guide to online non-hormonal menopause medication providers.
Medications for vaginal dryness and painful sex (GSM)
Vaginal dryness, painful sex, and related changes are grouped under “GSM” (genitourinary syndrome of menopause). The main FDA-approved medicines are low-dose vaginal estrogen, prasterone (Intrarosa), and ospemifene (Osphena). These often make more sense than whole-body hormones if your symptoms are mostly below the belt.
You can have vaginal symptoms without needing whole-body HRT — and you can have hot flashes without needing a vaginal medicine.They’re different problems with different fixes.
| Option | Example | Type | FDA-approved for | Watch out for |
|---|---|---|---|---|
| Vaginal estrogen | Estrace cream, Premarin cream, Vagifem, Yuvafem, Imvexxy, Estring | Low-dose, local estrogen | Vaginal dryness and painful sex (GSM) | Any unexplained bleeding — get it checked |
| Vaginal DHEA | Intrarosa (prasterone) | A DHEA (a steroid) vaginal insert | Moderate-to-severe painful sex due to menopause | Abnormal bleeding; discuss cancer history |
| Oral SERM | Osphena (ospemifene) | Acts like estrogen in some tissues, not others | Moderate-to-severe painful sex and vaginal dryness due to menopause | Has its own uterine and clot-risk cautions |
| Non-prescription | Moisturizers, lubricants | Not medicine | Everyday comfort (not a prescription treatment) | Won’t treat the underlying tissue change |
One reassuring note: low-dose vaginal estrogen puts very little estrogen into your bloodstream, and the Menopause Society has backed lifting its warning as a safe, effective option for a symptom most menopausal women eventually get. If dryness or painful sex is your issue, this is often a gentle place to start.
Patch, pill, gel, spray, ring, or cream — how do you choose?
Route matters because it changes convenience, cost, insurance coverage, skin comfort, and how much of the medicine reaches your whole body versus stays local.A patch, pill, gel, spray, vaginal ring, and vaginal cream can all be “menopause medications,” but they don’t all solve the same problem.
| Route | Usually used for | Upside | Tradeoff |
|---|---|---|---|
| Pill | Whole-body symptoms; most non-hormonal drugs | Familiar, often covered by insurance | Swallowed daily; goes through the liver first |
| Patch | Whole-body estrogen | Change once or twice a week; skips the liver | Can irritate skin; must stay stuck on |
| Gel / spray | Whole-body estrogen | Flexible dosing | Must let it dry; avoid skin-to-skin transfer to others |
| Vaginal cream | Vaginal/GSM symptoms | Adjustable dose | A little messy |
| Vaginal tablet / insert | Vaginal/GSM symptoms | Cleaner than cream | Follow the product’s schedule |
| Vaginal ring | Local or whole-body, depending on the product | Lasts longer between changes | Estring (local) and Femring (whole-body) are not the same — check which one |
For a side-by-side of all FDA-approved products by route, see the HRT medication comparison chart. For a cost breakdown by route, see our HRT cost guide.
How having a uterus changes your options
Whether you still have a uterus is one of the first questions that sorts the list. If you have a uterus and take whole-body estrogen, you generally need a progestogen (or a product like Duavee) to protect your uterine lining. If you’ve had a hysterectomy, estrogen-alone may be an option.
- You have a uterus? If systemic estrogen is on the table, ask: “How is my uterine lining being protected?” The usual answer is progesterone, a progestin, or a product designed to handle it.
- You had a hysterectomy? Ask whether that means you can skip the progestogen.
- Any unexplained bleeding?That’s a reason to be seen in person before starting anything online.
This is also why the 2026 label change didn’t touch everything. Even after the FDA removed the heart, breast, and dementia language from the boxed warning, it kept the warning about uterine cancer risk for estrogen-alone products in women who still have a uterus. That warning is doing an important job.
Are compounded or “bioidentical” hormones on the list?
Yes — women encounter compounded hormones and pellets constantly, so they belong on any honest 2026 list. But they go in their own lane: compounded preparations are not FDA-approved, and they are not equivalent to FDA-approved hormones.
A compoundedhormone is custom-mixed by a compounding pharmacy from a clinician’s prescription. It might be a cream, a capsule, a troche, or a pelletplaced under the skin. Compounding is legitimate for specific needs — say, a documented allergy to an ingredient in an approved product. But the compounded product itself hasn’t gone through the FDA’s testing. As the FDA puts it, compounded drugs are not FDA-approved, the FDA does not verify their safety, effectiveness, or quality before they’re sold, and they should be used only when a patient’s needs can’t be met by an FDA-approved drug.
A 2020 National Academies of Sciences report concluded the evidence doesn’t support routine use of compounded hormones and recommended FDA-approved products first. ACOG says compounded “bioidentical” hormone therapy shouldn’t be prescribed routinely when an FDA-approved option exists.
Ask these plain questions if a clinic leans on “natural,” “bioidentical,” or “custom”:
| Ask this | Why it matters |
|---|---|
| “Is this FDA-approved or compounded?” | You deserve to know which lane you’re in. |
| “Why compounded instead of an approved product?” | Approved options should usually be tried first. |
| “Which pharmacy makes it, and is the dose consistent?” | Custom mixing raises consistency questions. |
| “Is a pellet involved?” | Pellets are hard to adjust or stop once they’re in. |
None of this means compounding is never appropriate. It means you should choose it on purpose, with your eyes open. See our full FDA-approved vs. compounded HRT explainer.
What medications are used for low libido or HSDD around menopause?
Low desire around menopause is usually tackled in a specific order: rule out and treat pain or dryness first, then look at whether it’s HSDD — a diagnosis, not just a low-libido day. For diagnosed HSDD, Addyi (flibanserin) is now FDA-approved for women under 65, including postmenopausal women, as of December 2025. Vyleesi is approved only for premenopausal women. Testosterone has no FDA-approved product for women and is used off-label.
HSDDstands for hypoactive sexual desire disorder — persistent low sexual desire that genuinely distresses you and isn’t explained by a medical condition, a medication, or what’s happening in your relationship. It’s a real diagnosis, and it’s common.
- Addyi (flibanserin)— a non-hormonal daily pill taken at bedtime. In December 2025 the FDA expanded its approval to cover women under 65 with acquired, generalized HSDD — which, for the first time, includes postmenopausal women. The benefit in studies was modest, and there are real cautions: it can interact badly with alcohol and can cause low blood pressure or fainting, which is why it’s taken at bedtime. If it hasn’t helped after 8 weeks, it’s stopped.
- Vyleesi (bremelanotide)— an injection used before anticipated activity. FDA-approved for HSDD inpremenopausal women only, and is not approved for postmenopausal women or for men.
The straight talk on testosterone for women
There is no FDA-approved testosterone product for women in the United States as of 2026.Some clinicians consider it off-label for carefully diagnosed HSDD — but not for fatigue, brain fog, weight, or “hormone balance.” Testosterone is a Schedule III controlled substance, which means it always requires a prescription and proper medical oversight. Any source that makes getting it sound casual is waving a red flag.
| What the offer says | How to read it |
|---|---|
| “For HSDD, after an evaluation” | Reasonable — worth discussing with a clinician |
| “Fixes brain fog, fatigue, weight, or ‘hormone balance’” | Overreach — not what the evidence supports |
| “Pellets, and hard to adjust once placed” | Proceed with caution |
| “No prescription needed” | Stop — that’s a serious red flag |
The good news: postmenopausal women with diagnosed HSDD now have an FDA-approved oral option (Addyi) that didn’t exist for them a year ago — so testosterone isn’t the only path anymore. For who prescribes testosterone therapy, see which online HRT providers prescribe what.
Can you actually get these medications online?
Some menopause medications can be prescribed through online (telehealth) care — when the provider is licensed in your state, the medicine fits their offerings, and your health history is a good fit for remote care. Online isn’t the right starting point for everyone, especially with red flags like unexplained bleeding or a complex cancer, clotting, or liver history.
| Medication group | Online fit | Why |
|---|---|---|
| Local vaginal estrogen | Often a strong fit | Symptom-specific and commonly handled remotely when there are no red flags |
| Systemic FDA-approved HRT | Often possible | Needs a risk-history review and the uterus question answered |
| Non-hormonal hot-flash drugs | Often possible | Some (like Veozah) need lab monitoring the provider must manage |
| Low-desire / HSDD medication | Sometimes | Needs a real HSDD evaluation, not a quick add-on |
| Compounded hormones | Higher homework required | You need to confirm why it’s compounded and which pharmacy makes it |
| Testosterone | Usually specialist / high-caution | Not FDA-approved for women; needs careful diagnosis and monitoring |
| Complex history (bleeding, cancer, clots, liver) | Usually in person first | Needs a real evaluation beyond a general online intake |
What to verify before you pay for a consult
- FDA-approved or compounded? “Do you prescribe FDA-approved products, compounded products, or both?”
- Which forms? “Do you offer patches, pills, gels, vaginal estrogen, and non-hormonal options — or only certain ones?”
- The uterus question. “If I have a uterus, how do you handle progesterone?”
- Labs. “Do I need blood tests first, and who pays for them?”
- Insurance. “Do you take insurance, give a superbill, or is it cash-pay only?”
- Your state. “Are you licensed where I live?”
- If it’s not a fit. “What happens if online care isn’t right for me?”
How we review providers, in one box
The HRT Index Verification Standard is our documented process for reviewing telehealth providers — we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule (top providers monthly, the full roster quarterly). We judge providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access.We don’t hand out numeric scores, and we don’t rank anyone by commission.
Midi Health is an affiliate partner. See our affiliate disclosure. Provider facts verified July 2026— confirm current pricing and formulary at checkout.
How we built this list (and what we actually verified)
We built this list from primary and authoritative sources first — the FDA, drug labels on DailyMed, and major medical societies — then organized it into a decision map. Where something still needs checking, we say so.
What we verified
- The February 12, 2026 FDA label change and the exact six products updated — confirmed against the FDA’s press release and the FDA’s list of updated prescribing information.
- Veozah’s boxed warning for rare serious liver injury, its liver-testing schedule, its contraindications, and its trial results — from the FDA-approved DailyMed label.
- Lynkuet’s FDA approval on October 24, 2025 — from the FDA’s Drug Trials Snapshot and the manufacturer.
- Addyi’s expanded approval in December 2025 for women under 65 including postmenopausal women — from the FDA-approved label and the manufacturer’s announcement.
- Brisdelle as the only FDA-approved SSRI for hot flashes, and its tamoxifen caution — from DailyMed.
- That there is no FDA-approved testosterone product for women in the U.S., and that testosterone is a Schedule III controlled substance — per ACOG and the DEA.
- The compounded vs. FDA-approved distinction — per the FDA, ACOG, and the 2020 National Academies report.
We’re an editorial team, not your doctor. This page is here to make you a sharper, calmer patient — the actual prescribing decision belongs to you and a clinician who knows your history.
Menopause medications: frequently asked questions
Most menopause medication questions are really category questions — hormone or non-hormonal, whole-body or local, FDA-approved or compounded, online or in person. Here are the ones women ask us most.
- What is the best medication for menopause?
- There’s no single best medication for everyone, because symptoms and health histories differ. For hot flashes, systemic hormone therapy or FDA-approved non-hormonal drugs (Brisdelle, Veozah, Lynkuet) are common; for vaginal dryness or painful sex, local vaginal estrogen or medicines like Osphena and Intrarosa often fit better.
- What is the newest menopause medication in 2026?
- Lynkuet (elinzanetant), a non-hormonal pill approved on October 24, 2025, is the newest for hot flashes. Addyi’s approval also expanded in December 2025 to cover postmenopausal women under 65 with HSDD, so low-desire medication has its own updated section.
- Did the FDA remove the warning on hormone therapy?
- Starting in February 2026, the FDA began removing specific boxed-warning language — about heart disease, breast cancer, and dementia — from some menopausal hormone therapy labels. The first six products were updated on February 12, 2026, with more under review. It doesn’t remove every warning, and it doesn’t make hormone therapy risk-free.
- What are the names of common HRT medications?
- Common examples include estradiol and conjugated estrogen products (Estrace, Climara, Vivelle-Dot, Premarin), progesterone/progestin products (Prometrium, Provera), combinations (Bijuva, Prempro, Activella, CombiPatch), Duavee, and low-dose vaginal estrogen (Vagifem, Yuvafem, Estring, Imvexxy).
- Is there a non-hormonal menopause pill?
- Yes. Brisdelle (low-dose paroxetine), Veozah (fezolinetant), and Lynkuet (elinzanetant) are FDA-approved non-hormonal pills for hot flashes.
- Do I need progesterone with estrogen?
- If you have a uterus and take whole-body estrogen, you generally need a progestogen to protect your uterine lining. If you’ve had a hysterectomy or use only local vaginal estrogen, the answer may be different — ask your clinician.
- Are estrogen patches safer than pills?
- Patches, gels, and sprays skip the first pass through the liver that pills go through, which is one reason many clinicians favor them for certain women. But “safer” depends on your personal history, so this is a conversation, not a universal rule.
- Is vaginal estrogen the same as whole-body HRT?
- No. Low-dose vaginal estrogen mostly treats local symptoms like dryness and painful sex, with very little reaching your bloodstream. Whole-body (systemic) HRT is for symptoms like hot flashes and night sweats.
- Is Veozah a hormone?
- No. Veozah is a non-hormonal drug for moderate-to-severe hot flashes, but it carries a boxed warning for rare liver injury and requires liver blood tests during treatment.
- Are “bioidentical” hormones FDA-approved?
- Some are. FDA-approved bioidentical options include estradiol, micronized progesterone, and the combination Bijuva. Compounded “bioidentical” hormones mixed by a pharmacy are not FDA-approved.
- Is there an FDA-approved pill for low libido after menopause?
- Yes, as of December 2025: Addyi (flibanserin) is now FDA-approved for HSDD in women under 65, including postmenopausal women. It treats a specific diagnosis (HSDD), not general low energy or “hormone balance.”
- Is testosterone FDA-approved for menopause in women?
- No. As of 2026 there’s no FDA-approved testosterone product for women in the U.S. It’s sometimes used off-label for diagnosed low sexual desire (HSDD), and it’s a Schedule III controlled substance that requires a prescription and monitoring.
- Can I get menopause medication online?
- Often, yes — if the provider is licensed in your state, the medicine fits their offerings, and your history is a good fit for telehealth. Some situations, like unexplained bleeding or a complex medical history, should be seen in person first.
Still not sure which HRT program is right for you?
Menopause is a normal stage of life, but its symptoms can make daily life genuinely hard — and 2026 gives you more real, tested options than women have had in a long time. Take our free matching quiz — it takes about 90 seconds.
Related reading from The HRT Index
- HRT medication comparison chart 2026 — every FDA-approved form, side by side
- FDA-approved HRT medication list 2026 — full reference by type and route
- FDA-approved vs. compounded HRT — the regulatory difference, plainly explained
- Vaginal estrogen guide — local vs. systemic, all options in detail
- HRT benefits, risks & who it’s right for — the safety picture, updated for 2026
- HRT side effects — what to expect and when to call your clinician
- Best online providers for non-hormonal menopause medication — Veozah, Lynkuet, Brisdelle, and who prescribes them
- Which online HRT providers prescribe what — provider-by-form medication map
- How much does HRT cost in 2026? — real prices by form and provider
- Best online HRT providers for menopause — ranked on our five-pillar standard
Sources
- FDA — FDA Approves Labeling Changes to Menopausal Hormone Therapy Products (Feb 12, 2026). fda.gov
- FDA — Menopausal Hormone Therapies with Updated Prescribing Information. fda.gov
- FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms. fda.gov
- FDA — FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant). fda.gov
- DailyMed — Veozah (fezolinetant) label (monitoring, contraindications, trial results). dailymed.nlm.nih.gov
- FDA — Drug Trials Snapshots: Lynkuet (approval Oct 24, 2025). fda.gov
- Bayer — Lynkuet (elinzanetant) FDA approval (Oct 24, 2025). bayer.com
- Urology Times / Sprout Pharmaceuticals — FDA approves flibanserin (Addyi) for HSDD in postmenopausal women under 65 (Dec 15, 2025). urologytimes.com
- DailyMed — Brisdelle (paroxetine 7.5 mg) label. dailymed.nlm.nih.gov
- ACOG — Hormone Therapy for Menopause. acog.org
- ACOG — Compounded Bioidentical Menopausal Hormone Therapy (2023). acog.org
- FDA — Compounding and the FDA: Questions and Answers. fda.gov
- DEA — Drug Scheduling (testosterone, Schedule III). dea.gov
- The Menopause Society — Comments on the FDA Announcement on Hormone Therapy (Nov 2025). menopause.org
- GoodRx — Hormone Replacement Therapy for Menopause. goodrx.com
- National Academies of Sciences, Engineering, and Medicine (2020) — The Clinical Utility of Compounded Bioidentical Hormone Therapy. nationalacademies.org
This page is educational and is not medical advice. Always talk with a licensed clinician about your individual symptoms, history, and risks before starting or changing any treatment. Find My HRT Path is covered by our consumer health data and privacy policy. See our affiliate disclosure.